Source 1review2022Frontiers in Reproductive Health
Toolkit/endometrial thickness measurements
endometrial thickness measurements
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Endometrial thickness measurement is a current clinical assay method used as a marker of the window of implantation and endometrial receptivity. The cited evidence indicates that, as a current test of the window of implantation, it does not consistently improve clinical outcomes measured by live birth rates.
Usefulness & Problems
Why this is useful
This assay is used clinically as a marker intended to assess the window of implantation. The supplied evidence supports its role as a current receptivity test but indicates limited demonstrated utility for improving live birth outcomes.
Problem solved
Endometrial thickness measurement is intended to help assess endometrial receptivity during the window of implantation. However, the cited literature states that the biological basis of current clinical markers or tests of the window of implantation is poor.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The supplied evidence identifies this tool as a clinical assay method and marker of the window of implantation. No practical details on measurement modality, timing, cutoff values, instrumentation, or sample handling are provided in the supplied evidence.
The cited review states that current tests of the window of implantation, including endometrial thickness measurements, do not consistently improve clinical outcomes as measured by live birth rates. It also states that the biological basis of current clinical markers or tests of the window of implantation is poor.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug endometrial-thickness-measurements
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Source:
biological rationale limitationsupports
The biological basis of current clinical markers or tests of the window of implantation is poor.
The biological basis of current clinical markers or tests of window of implantation is poor.
Source:
clinical utility limitationsupports
Current tests of the window of implantation, including endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes measured by live birth rates.
Current tests of the window of implantation, such as endometrial thickness measurements and the endometrial receptivity assay, do not consistently improve clinical outcomes as measured by live birth rates.
Source:
Comparisons
Source-backed strengths
The available evidence establishes that endometrial thickness measurement is already used as a current clinical test of the window of implantation. No specific performance strengths, predictive accuracy metrics, or outcome benefits are provided in the supplied evidence.
Compared with Field-domain rapid-scan EPR at 240 GHz
endometrial thickness measurements and Field-domain rapid-scan EPR at 240 GHz address a similar problem space.
Shared frame: same top-level item type
Compared with fluorescence line narrowing
endometrial thickness measurements and fluorescence line narrowing address a similar problem space.
Shared frame: same top-level item type
Compared with native green gel system
endometrial thickness measurements and native green gel system address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Ranked Citations
- 1.